Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Farde

Showing results (111-120 of 207) with videos related to

Pageof 21
Sort By:
Nuclear Medicine and Biology|November 1, 1995
PET examination of the monkey heart with high specific radioactivity [11C]norepinephrine and [11C]metaraminolL Farde, C Halldin, K Någren, et al.
EXS|January 1, 1994
PET-determination of benzodiazepine receptor binding in studies on alcoholismL Farde, S Pauli, J E Litton, et al.
The Israel Journal of Psychiatry and Related Sciences|January 1, 1995
Recent developments in PET scan imaging of neuroreceptors in schizophreniaG Sedvall, S Pauli, L Farde, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Drug interaction studies with remoxiprideW Yisak, C von Bahr, L Farde, et al.
Synapse (New York, N.Y.)|June 1, 1996
Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epideprideH Hall, L Farde, C Halldin, et al.
Clinical Pharmacokinetics|February 1, 1992
Pharmacokinetics of raclopride formulations. Influence of prolactin and tolerability in healthy male volunteersG Movin-Osswald, A L Nordström, M Hammarlund-Udenaes, et al.
Neuroscience|April 8, 2009
Age-related loss of olfactory sensitivity: association to dopamine transporter binding in putamenM Larsson, L Farde, T Hummel, et al.
Psychopharmacology|January 1, 1993
Interaction study between remoxipride and biperidenW Yisak, L Farde, C von Bahr, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1994
Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's diseaseG Sedvall, P Karlsson, A Lundin, et al.
Archives of General Psychiatry|July 1, 1987
No D2 receptor increase in PET study of schizophreniaL Farde, F A Wiesel, H Hall, et al.
Pageof 21

Showing results (111-120 of 207) with videos related to

Sort By:
Pageof 21
Nuclear Medicine and Biology|November 1, 1995
PET examination of the monkey heart with high specific radioactivity [11C]norepinephrine and [11C]metaraminolL Farde, C Halldin, K Någren, et al.
EXS|January 1, 1994
PET-determination of benzodiazepine receptor binding in studies on alcoholismL Farde, S Pauli, J E Litton, et al.
The Israel Journal of Psychiatry and Related Sciences|January 1, 1995
Recent developments in PET scan imaging of neuroreceptors in schizophreniaG Sedvall, S Pauli, L Farde, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Drug interaction studies with remoxiprideW Yisak, C von Bahr, L Farde, et al.
Synapse (New York, N.Y.)|June 1, 1996
Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epideprideH Hall, L Farde, C Halldin, et al.
Clinical Pharmacokinetics|February 1, 1992
Pharmacokinetics of raclopride formulations. Influence of prolactin and tolerability in healthy male volunteersG Movin-Osswald, A L Nordström, M Hammarlund-Udenaes, et al.
Neuroscience|April 8, 2009
Age-related loss of olfactory sensitivity: association to dopamine transporter binding in putamenM Larsson, L Farde, T Hummel, et al.
Psychopharmacology|January 1, 1993
Interaction study between remoxipride and biperidenW Yisak, L Farde, C von Bahr, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1994
Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's diseaseG Sedvall, P Karlsson, A Lundin, et al.
Archives of General Psychiatry|July 1, 1987
No D2 receptor increase in PET study of schizophreniaL Farde, F A Wiesel, H Hall, et al.
Pageof 21